VI
VIR
Market ClosedVir Biotechnology, Inc.
US
408 employees
CEO: Marianne De Backer
Founded: 2019
$8.61
+$0.00(+NaN%)
Market Cap
1.45B
Beta
1.64
52W Range
N/A
Dividend Yield
0.00%
VIR Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for VIR built from valuation, fundamentals, sentiment, and risk models
Investment Signal
Strong SellPass %
28.57%
Score
2/7
Fair Value Estimate
Cash flow analysis • Multiple methods
-$73.77
AI Price Target
Machine learning • Price prediction
$8.87
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$0.00
Financial Health
Bankruptcy risk assessment
1.36
Quality Score
Financial strength rating
3.00
AI Investment Grade
Deep analysis of filings & news
62.00
Key Investment Highlights
Important factors affecting VIR investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
31.58% Poor
Conditions Met
12.00/38.00
Due Diligence Score
31.58%Due Diligence Conditions
Investment analysis conditions and results
Fail | |
Fail | |
Fail | |
Fail | |
Fail | |
Fail |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for VIR
No recent news available for VIR
Core Financials
Loading financial data for VIR...
Explore VIR
VIR in the Healthcare
Small Cap